Isn't the whole point of any listed biotech ongoing scientific research into whatever field they choose to specialise in? In EX1's case they will likely be purchased by big pharma for multiple billion $ before even reaching the FDA stage, given their field of research.
- Forums
- ASX - By Stock
- TYP
- Codiak ($800mil market capitalisation)
Codiak ($800mil market capitalisation), page-178
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TYP (ASX) to my watchlist
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.69M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $13.68K | 720.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 222055 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 534800 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 222055 | 0.019 |
5 | 1381453 | 0.018 |
1 | 500000 | 0.017 |
2 | 391565 | 0.016 |
1 | 400000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 534800 | 2 |
0.021 | 100000 | 2 |
0.022 | 508953 | 3 |
0.023 | 403477 | 3 |
0.024 | 140529 | 2 |
Last trade - 11.58am 10/09/2024 (20 minute delay) ? |
Featured News
TYP (ASX) Chart |